p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
The expression of enzymes involved in fatty acid beta-oxidation (FAO), the principal source of energy production in the adult mammalian heart, is controlled at the transcriptional level via the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha). Evidence has emerged that PPARalpha activity is activated as a component of an energy metabolic stress response. The p38 mitogen-activated protein kinase (MAPK) pathway is activated by cellular stressors in the heart, including ischemia, hypoxia, and hypertrophic growth stimuli. We show here that PPARalpha is phosphorylated in response to stress stimuli in rat neonatal cardiac myocytes; in vitro kinase assays demonstrated that p38 MAPK phosphorylates serine residues located within the NH(2)-terminal A/B domain of the protein. Transient transfection studies in cardiac myocytes and in CV-1 cells utilizing homologous and heterologous PPARalpha target element reporters and mammalian one-hybrid transcription assays revealed that p38 MAPK phosphorylation of PPARalpha significantly enhanced ligand-dependent transactivation. Cotransfection studies performed with several known coactivators of PPARalpha demonstrated that p38 MAPK markedly increased coactivation specifically by PGC-1, a transcriptional coactivator implicated in myocyte energy metabolic gene regulation and mitochondrial biogenesis. These results identify PPARalpha as a downstream effector of p38 kinase-dependent stress-activated signaling in the heart, linking extracellular stressors to alterations in energy metabolic gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing evidence suggests that modifications can result in distinct effects on PGC-1α activity in a manner that is a) stimulus dependent and b) tissue dependent.”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [74]
In the citing paper
“the mitogen activated kinase p38 has been reported to increase PGC-1α activity upon stress in cardiac myocytes [74], in response to cytokines in myotubes [34] and is required for activation of PGC-1α through calcium calmodulin signaling pathway [75] or in response to trophic factors at the neuromuscular junction [76].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [74]
In the citing paper
“PPARα ligand dependent transcriptional activity and co-activation by PGC-1α is activated in heart by stress including ischemia, and hypoxia [74]”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [74]
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Self-citationVega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
Self-citationInhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
Hu, E., Kim, J. B., Sarraf, P., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5295.2100 · Cited by 1,050
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Self-citationWang, Y., Huang, S., Sah, V. P., Ross, J., Brown, J. H., Han, J., & Chien, K. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2161 · Cited by 842
Fatty Acid Oxidation Enzyme Gene Expression Is Downregulated in the Failing Heart
Sack, M. N., Rader, T. A., Park, S., Bastin, J., McCune, S. A., & Kelly, D. P. (1996) · Circulation · doi:10.1161/01.cir.94.11.2837 · Cited by 677
Self-citationGulick, T., Cresci, S., Caira, T., Moore, D. D., & Kelly, D. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11012 · Cited by 560
Self-citation
Research works printed but not linked: 2
- Horowitz, 2000, Am. J. Physiol., 279, E348
- Baes, 1994, Mol. Cell. Biol., 14, 1544
Cited by
Items 101–200 of 266
PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells
Tordjman, K. M., Standley, K. N., Bernal‐Mizrachi, C., Leone, T. C., Coleman, T., Kelly, D. P., & Semenkovich, C. F. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30468-5 · Cited by 90
Self-citationLiu, Z., & Cao, W. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009787582397 · Cited by 88
Zhang, C., Li, L., Jiang, Y., Wang, C., Geng, B., Wang, Y., Chen, J., Liu, F., Qiu, P., Zhai, G., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700208rr · Cited by 82
Videla, L. A., & Pettinelli, P. (2012) · PPAR Research · doi:10.1155/2012/107434 · Cited by 89
“This is achieved by APPL1 (adaptor protein containing phosphotyrosine binding, pleckstrin homology domains, and leucine zipper 1) that couples adiponectin receptors to AMPK activation [91], with the sequential activation of p38 mitogen-activated protein kinase (p38 MAPK) [92] that phosphorylates PPAR-α, thus increasin…”
BackgroundMeng, R., Pei, Z., Zhang, A., Zhou, Y., Cai, X., Chen, B., Guanjie, L., Mai, W., Wei, J., & Dong, Y. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.04.010 · Cited by 79
Zhang, P., Wang, Y., Fan, Y., Tang, Z., & Wang, N. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178061 · Cited by 78
Hwang, S., Wang, X., Rodrigues, R. M., Ma, J., He, Y., Seo, W., Park, S. H., Kim, S., Feng, D., & Gao, B. (2020) · Hepatology · doi:10.1002/hep.31390 · Cited by 73
Sildenafil for the Treatment of Alzheimer’s Disease: A Systematic Review
Sanders, O. (2020) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-200166 · Cited by 77
Oberkofler, H., Esterbauer, H., Linnemayr, V., Strosberg, A. D., Krempler, F., & Patsch, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200475200 · Cited by 76
Role of mitochondria in pathogenesis and therapy of renal fibrosis
Zhao, X., Li, Y., Yu, J., Teng, H., Wu, S., Wang, Y., Zhou, H., & Li, F. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155913 · Cited by 76
Cardiac nuclear receptors: architects of mitochondrial structure and function
Vega, R. B., & Kelly, D. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88888 · Cited by 76
Self-citationMaik-Rachline, G., Lifshits, L., & Seger, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176102 · Cited by 77
Tian, Z., Miyata, K., Kadomatsu, T., Horiguchi, H., Fukushima, H., Tohyama, S., Ujihara, Y., Okumura, T., Yamaguchi, S., Zhao, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13016 · Cited by 70
Kim, N., Nam, M., Kang, M. S., Lee, J. O., Lee, Y. W., Hwang, G., & Kim, H. S. (2017) · Scientific Reports · doi:10.1038/srep41066 · Cited by 78
Metabolic Reprogramming in Dietary Restriction
Anderson, R. M., & Weindruch, R. (2006) · Interdisciplinary Topics in Gerontology · doi:10.1159/000096554 · Cited by 67
Wang, Y., & Zidichouski, J. A. (2018) · Cholesterol · doi:10.1155/2018/7173920 · Cited by 76
Sarg, N. H., Zaher, D. M., Jayab, N. N. A., Mostafa, S. H., Ismail, H. H., & Omar, H. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116307 · Cited by 70
Control of nuclear receptor activities in metabolism by post‐translational modifications
Berrabah, W., Aumercier, P., Lefèbvre, P., & Staels, B. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.066 · Cited by 69
Howroyd, P., Swanson, C., Dunn, C., Cattley, R. C., & Corton, J. C. (2004) · Toxicologic Pathology · doi:10.1080/01926230490515283 · Cited by 65
“In the heart, PPARα was identified as a downstream effector of p38 kinase-dependent stress-activated signaling, linking extracellular stressors to alterations in energy metabolic gene expression (Barger et al., 2001).”
BackgroundKinase signaling cascades that modulate peroxisome proliferator-activated receptors
Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.002 · Cited by 73
Warren, J. S., Oka, S., Zablocki, D., & Sadoshima, J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00103.2017 · Cited by 69
Barreto‐Torres, G., Hernández, J. S., Jang, S., Rodríguez‐Muñoz, A., Torres‐Ramos, C. A., Basnakian, A. G., & Javadov, S. A. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00414.2014 · Cited by 68
Azimzadeh, O., Sievert, W., Sarioglu, H., Yentrapalli, R., Barjaktarović, Ž., Sriharshan, A., Ueffing, M., Janik, D., Aichler, M., Atkinson, M. J., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400071g · Cited by 65
Shabrova, E. V., Olga, T., Singh, A. P., Plutzky, J., Vorsa, N., & Quadro, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024634 · Cited by 62
“Phosphorylation of PPARa also markedly increases coactivation by PGC-1a and significantly enhances ligand-dependent transactivation [62].”
BackgroundElucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
Khuchua, Z. A., Glukhov, A. I., Strauss, A. W., & Javadov, S. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113464 · Cited by 65
Burelle, Y., Khairallah, M., Ascah, A., Allen, B. G., Deschepper, C. F., Petrof, B. J., & Rosiers, C. D. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.09.004 · Cited by 68
“However, another signaling pathway that could help explain the metabolic shift observed in the perfused mdx heart is the p38 MAPK pathway, which has been shown to be involved in regulating substrate energy metabolism [63] through the nuclear receptor peroxisome proliferator-activated receptor (PPARα), a transcriptiona…”
BackgroundChistyakov, D. V., Aleshin, S. E., Astakhova, A. A., Sergeeva, M. G., & Reiser, G. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13101 · Cited by 63
“In most cases, stimuli-induced phosphorylation of PPARa is an effect that is associated with increased transcriptional activity (Shalev et al. 1996; Barger et al. 2001).”
BackgroundMAP kinase phosphatase DUSP1 is overexpressed in obese humans and modulated by physical exercise
Khadir, A., Tiss, A., Abubaker, J., Abu-Farha, M., Al-Khairi, I., Cherian, P., John, J., Kavalakatt, S., Warsame, S., Al-Madhoun, A., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00577.2013 · Cited by 60
Li, L., Wu, L., Wang, C., Liu, L., & Zhao, Y. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.10.007 · Cited by 61
Regulation of the transcriptional activity of nuclear receptors by the MEK/ERK1/2 pathway
Zassadowski, F., Rochette‐Egly, C., Chomienne, C., & Cassinat, B. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.08.003 · Cited by 60
Tritos, N. A., Mastaitis, J. W., Kokkotou, E. G., Puigserver, P., Spiegelman, B. M., & Maratos–Flier, E. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03961-6 · Cited by 61
Flach, R. J. R., Hui, Q., Zhang, L., & Bennett, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210237 · Cited by 56
Färber, G., Barreto, F., Schoepe, M., Gilsbach, R., Schrepper, A., Schwarzer, M., Mohr, F. W., Hein, L., & Doenst, T. (2010) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.03.029 · Cited by 65
Lloret, A., & Beal, M. F. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02809-1 · Cited by 52
Diurnal variations in myocardial metabolism
Bray, M. S., & Young, M. E. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn054 · Cited by 51
Gianni’, M., Couturier‐Tarrade, A., Nigro, E. A., Garattini, E., & Rochette‐Egly, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304952200 · Cited by 57
Regulation of Peroxisome Proliferator-Activated Receptor α by Protein Kinase C
Gray, J. P., Burns, K. A., Leas, T. L., Perdew, G. H., & Heuvel, J. P. V. (2005) · Biochemistry · doi:10.1021/bi050721g · Cited by 56
Moore, M. L. G., Park, E. A., & McMillin, J. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210486200 · Cited by 52
Phosphorylation of Steroidogenic Factor 1 Is Mediated by Cyclin-Dependent Kinase 7
Lewis, A. E., Rusten, M., Hoivik, E. A., Vikse, E. L., Hansson, M. L., Wallberg, A. E., & Bakke, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2006-0478 · Cited by 44
Wagner, R. A., Tabibiazar, R., Powers, J. C., Bernstein, D., & Quertermous, T. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.09.003 · Cited by 44
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target
Rupp, H., & Zarain‐Herzberg, Á. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.3.345 · Cited by 44
Singh, A., & Chaudhary, R. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114616 · Cited by 44
Rim, J. S., Xue, B., Gawrońska‐Kozak, B., & Kozak, L. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402102200 · Cited by 45
Wang, Y., Wang, Y., Yang, Q., Yan, J., Zhao, C., Cianflone, K., & Wang, D. W. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.008 · Cited by 43
Stauber, A. J., Brown‐Borg, H. M., Liu, J., Waalkes, M. P., Laughter, A., Staben, R. A., Coley, J. C., Swanson, C. L., Voss, K. A., Kopchick, J. J., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007278 · Cited by 42
“With this in mind, mitogen-activated protein kinase activates PPAR through the AF-1 activation domain important for insulindependent signaling (Juge-Aubry et al., 1999) and cardiac metabolic stress responses (Barger et al., 2001).”
BackgroundSheldrick, E. L. R., Derecka, K., Marshall, E., Chin, E. C., Hodges, L., Wathes, D. C., Abayasekara, D. R. E., & Flint, A. P. F. (2007) · Biochemical Journal · doi:10.1042/bj20070089 · Cited by 41
Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases
Bedu, E., Wahli, W., & Desvergne, B. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.861 · Cited by 46
Different ways to regulate the PPAR$alpha; stability
Blanquart, C., Mansouri, R. M., Fruchart, J., Staels, B., & Glineur, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.035 · Cited by 43
Staudinger, J. L., & Lichti-Kaiser, K. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700098c · Cited by 41
Thioredoxin-interacting protein and myocardial mitochondrial function in ischemia–reperfusion injury
Yoshioka, J., & Lee, R. T. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.06.007 · Cited by 40
“TXNIP binds to the catalytic cysteines of thioredoxin and displaces ASK1 from thioredoxin, leading to activation of p38 MAP kinase, which can then activate PPARα in cardiomyocytes (Barger et al., 2001).”
Docosahexaenoic Acid as Master Regulator of Cellular Antioxidant Defenses: A Systematic Review
Borgonovi, S. M., Iametti, S., & Nunzio, M. D. (2023) · Antioxidants · doi:10.3390/antiox12061283 · Cited by 41
Peroxisome Proliferator‐Activated Receptors: Potential Therapeutic Targets in Lung Disease?
Denning, G. M., & Stoll, L. L. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20338 · Cited by 39
Morris, G., Sominsky, L., Walder, K. R., Berk, M., Marx, W., Carvalho, A. F., Bortolasci, C. C., Maes, M. H. J., & Puri, B. K. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02800-y · Cited by 41
ANGPTL6 expression is coupled with mitochondrial OXPHOS function to regulate adipose FGF21
Kang, S., Yi, H., Choi, M. J., Ryu, M. J., Jung, S.-B., Chung, H. K., Chang, J. Y., Kim, Y. K., Lee, S. E., Kim, H. W., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0549 · Cited by 37
“A previous study demonstrated that p38 MAPK phosphorylates and activates the transcription factor PPARα in cardiac myocytes (Barger et al. 2001).”
BackgroundDing, L., Liang, X., Zhu, D., & Lou, Y. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00648.x · Cited by 39
Fucci, A., Colangelo, T., Votino, C., Pancione, M., Sabatino, L., & Colantuoni, V. (2012) · PPAR Research · doi:10.1155/2012/242498 · Cited by 38
Cerbone, A., Toaldo, C., Pizzimenti, S., Pettazzoni, P., Dianzani, C., Minelli, R., Ciamporcero, E. S., Roma, G., Dianzani, M. U., Canaparo, R., et al. (2012) · PPAR Research · doi:10.1155/2012/269751 · Cited by 36
Sekiguchi, K., Tian, Q., Ishiyama, M., Burchfield, J., Gao, F., Mann, D. L., & Barger, P. M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01056.2006 · Cited by 36
Self-citationKang, H.-M., Lee, J.-S., Lee, Y. H., Kim, M., Park, H. G., Jeong, C., & Lee, J. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2018.10.020 · Cited by 35
SanGiovanni, J. P., Chen, J., Sapieha, P., Aderman, C. M., Stahl, A., Clemons, T. E., Chew, E. Y., & Smith, L. E. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053155 · Cited by 35
“[26,34,35,36] Via co-activation of PPARA [37,38,39,40], PPARGC1A may alter expression of CFH [41], and C2.”
BackgroundLarade, K., & Storey, K. B. (2005) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2005.10.008 · Cited by 33
Wall, J. A., Wei, J., Ly, M., Belmont, P. J., Martindale, J. J., Tran, D. H., Sun, J., Chen, W. J., Yu, W., Oeller, P. W., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01311.2005 · Cited by 35
Tu, J., Zhu, S.-L., Li, B., Xu, G., Luo, X., Jiang, L., Yan, X., Zhang, R., & Chen, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00811 · Cited by 33
“…SIRT1 expression may be attributed to inhibit PPARg adipogenesis activity and activate PPARa activity through differentiated recruitment of cofactors including PGC-1a for mitochondrial energy homeostasis (Figure 9C) (Barger et al., 2001; Kim et al., 2013; Banks et al., 2015; Brunmeir and Xu, 2018).”
BackgroundPeroxisome Proliferator-Activated Receptors and Atherosclerosis
Šoškić, S., Dobutović, B., Sudar-Milovanovic, E. M., Obradovic, M. M., Nikolić, D., Zarić, B. L., Stojanović, S. Đ., Stokić, E., Mikhailidis, D. P., & Isenović, E. R. (2011) · Angiology · doi:10.1177/0003319711401012 · Cited by 34
“Also, stressactivated p38 MAPK has been shown to phosphorylate PPARa and enhance target gene expression in myocardiocytes.(35) Several studies demonstrate that MAPK phosphorylation deactivates PPARg and reduces basal and ligand-dependent transcriptional activity.”
BackgroundLettieri‐Barbato, D., Baldelli, S., Pagliei, B., Aquilano, K., & Ciriolo, M. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/759583 · Cited by 35
“Energenetics” of Heart Failure
van Bilsen, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1302.020 · Cited by 39
Wogonin suppresses osteopontin expression in adipocytes by activating PPARα
Zhang, Y., Li, M., Tang, Z., & Wang, C. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.37 · Cited by 31
Xiao, Y., Wang, J., Yan, W., Zhou, K., Cao, Y., & Cai, W. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.523 · Cited by 29
IL-6 Is Not Necessary for the Regulation of Adipose Tissue Mitochondrial Content
Wan, Z., Perry, C. G. R., Macdonald, T., Chan, C. B., Holloway, G. P., & Wright, D. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051233 · Cited by 28
“such as heart [2,4,5] and skeletal muscle [6,7].”
BackgroundLiang, H., Dhar, S. S., & Wong‐Riley, M. T. T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22222 · Cited by 29
“…muscular activity or in response to cardiac metabolic stressor is thought to involve the p38 mitogen-activated protein kinase (MAPK) pathway (Barger et al., 2001; Akimoto et al., 2005; Wright et al., 2007a), which, in turn, is regulated by a calcium/calmodulindependent protein kinase…”
BackgroundPeroxisome Proliferator-Activated Receptors
Heuvel, J. P. V., & Peters, J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00209-8 · Cited by 30
Skeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: Endocrine aspects
Aguer, C., & Harper, M. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.06.001 · Cited by 31
The role of PPAR in myocardial response to ischemia in normal and diseased heart
Ravíngerová, T., Adameová, A., Čarnická, S., Nemčeková, M., Kelly, T., Matějíková, J., Galatou, E., Barlaka, E., & Lazou, A. (2011) · General Physiology and Biophysics · doi:10.4149/gpb_2011_04_329 · Cited by 28
“In fact, phosphorylation by extracellular signal regulated kinases (ERK1/2) has been found to repress PPAR-α activity (Barger and Kelly 2000; Barger et al. 2000), while phosphorylation induced by p38-MAPK enhances PPAR-α-mediated gene expression (Barger et al. 2001).”
BackgroundLuo, G., Xu, X., Guo, W. J., Luo, C., Wang, H., Meng, X., Zhu, S., & Wei, Y. (2015) · Peptides · doi:10.1016/j.peptides.2015.07.001 · Cited by 30
Tanaka‐Yachi, R., Takahashi-Muto, C., Adachi, K., Tanimura, Y., Aoki, Y., Koike, T., & Kiyose, C. (2017) · Journal of Oleo Science · doi:10.5650/jos.ess16137 · Cited by 28
Reactive oxygen at the heart of metabolism
Murray, T. V., Ahmad, A. N., & Brewer, A. C. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.09.003 · Cited by 27
Aswani, B. S., Hegde, M., Vishwa, R., Alqahtani, M. S., Abbas, M., Almubarak, H. A., Sethi, G., & Kunnumakkara, A. B. (2024) · Military Medical Research · doi:10.1186/s40779-024-00564-1 · Cited by 27
Mitogen-activated protein kinase phosphatase-1 – a potential therapeutic target in metabolic disease
Flach, R. J. R., & Bennett, A. M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.528395 · Cited by 26
Luo, Y., Zhang, Y.-N., Zhang, H., Lv, H., Zhang, M., Chen, L., & Du, Z. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.09.062 · Cited by 26
Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
Chung, S., & Park, C. W. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.4.327 · Cited by 25
Sharma, V. S., & McNeill, J. H. (2011) · World Journal of Cardiology · doi:10.4330/wjc.v3.i9.281 · Cited by 23
Huang, Q., You, J., Wang, X., Bu, X., Song, Y., Zhang, C., Du, Z., Shi, Q., Qin, J., & Chen, L. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.738123 · Cited by 23
Pioglitazone reverses down-regulation of cardiac PPARγ expression in Zucker diabetic fatty rats
Pelzer, T., Jazbutyte, V., Arias-Loza, P.-A., Segerer, S., Lichtenwald, M., Law, M. P., Schäfers, M. A., Ertl, G., & Neyses, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.029 · Cited by 22
The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity
Li, X., Zheng, L., Zhang, B., Deng, Z., & Luo, T. F. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.913883 · Cited by 33
Peroxisome Proliferator-Activated Receptor ?? and Hypertensive Heart Disease
Goikoetxea, M. J., Beaumont, J., & ez, J. D. (2004) · Drugs · doi:10.2165/00003495-200464002-00003 · Cited by 22
Malliou, F., Andriopoulou, C. E., Gonzalez, F. J., Kofinas, A., Skaltsounis, A., & Konstandi, M. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000302 · Cited by 21
Effect of TNFα on activities of different promoters of human apolipoprotein A-I gene
Orlov, S., Mogilenko, D. A., Shavva, V. S., Dizhe, E. B., Ignatovich, I. A., & Ap, P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.064 · Cited by 20
Liang, H., Xu, G., Xu, P., Zhu, J. X., Li, S., & Ren, M. (2022) · Aquaculture Nutrition · doi:10.1155/2022/4034922 · Cited by 23
“is one of the key coactivators in the regulation of fatty acid catabolism by PPARα in the cardiac metabolic stress response [52].”
BackgroundIntegrin-Dependent Akt1 Activation Regulates PGC-1 Expression and Fatty Acid Oxidation
Beeson, C., Beeson, G. C., Buff, H., Eldridge, J. D., Zhang, A., Seth, A. K., Demcheva, M. V., Vournakis, J. N., & Muise‐Helmericks, R. C. (2012) · Journal of Vascular Research · doi:10.1159/000332326 · Cited by 25
Ding, L., Liang, X., & Lou, Y. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00558.x · Cited by 19
Montessuit, C., Palma, T., Viglino, C., Pellieux, C., & Lerch, R. A. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0059-4 · Cited by 21
Evidence for Cross Talk between PPARalpha and p38 MAP Kinase
Roberts, R. A. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.2.270 · Cited by 20
Adiponectin-mediated regulation of the adiponectin cascade in cardiovascular disease: Updates
Hafiane, A. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149406 · Cited by 17
δ-Tocopherol promotes thermogenic gene expression via PGC-1α upregulation in 3T3-L1 cells
Tanaka‐Yachi, R., Shirasaki, M., Otsu, R., Takahashi-Muto, C., Inoue, H., Aoki, Y., Koike, T., & Kiyose, C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.021 · Cited by 19
MEK1 Inhibits Cardiac PPARα Activity by Direct Interaction and Prevents Its Nuclear Localization
el Azzouzi, H., Leptidis, S., Bourajjaj, M., van Bilsen, M., Martins, P. A. D. C., & Windt, L. J. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036799 · Cited by 17
“Although it was previously shown that activated ERK1/2 is able to phosphorylate PPARa [11], site-directed mutagenesis of all of the putative serine ERK1/2 phosphorylation target sites showed no difference to the MEK1 induced inhibition of PPARa transcriptional activity.”
BackgroundInvolvement of ZIP/p62 in the regulation of PPARα transcriptional activity by p38-MAPK
Diradourian, C., May, C. L., Caüzac, M., Girard, J. R., Burnol, A., & Pégorier, J. P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.02.002 · Cited by 19
“Indeed, in cardiomyocytes, p38-MAPK phosphorylation enhanced the liganddependent recruitment of PGC-1 co-activator leading to an activation of PPARα transcriptional activity [11].”
BackgroundResultInfluentialCovalent Plant Natural Product that Potentiates Antitumor Immunity
Takemoto, M., Delghandi, S., Abo, M., Yurimoto, K., Odagi, M., Singh, V. P., Wang, J., Nakagawa, R., Sato, S., Takemoto, Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c17837 · Cited by 17
Mitochondrial fusion proteins in revascularized hibernating hearts
Holley, C. T., Long, E. K., Butterick, T. A., Duffy, C. M., Lindsey, M. E., Stone, L. H., McFalls, E. O., & Kelly, R. F. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2014.12.052 · Cited by 14
Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH
Bogazzi, F., Raggi, F., Ultimieri, F., Russo, D., D’Alessio, A., Manariti, A., Brogioni, S., Manetti, L., & Martino, E. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0194 · Cited by 14
“Variations of PPARa expression in hypertrophic hearts had been linked to p38 or ERK 1/2 activation (Barger et al. 2000, 2001).”
BackgroundThe PPARΩPocket: Renewed Opportunities for Drug Development
Kaupang, Å., & Hansen, T. V. (2020) · PPAR Research · doi:10.1155/2020/9657380 · Cited by 16
“Coherently, the AF-1 region has been demonstrated to influence the selectivity with which each PPAR subtype regulates the expression of its target genes [3], but also the degree of transcriptional activation induced by ligand binding [62].”
Background
Metadata
- Authors
- Barger, P. M., Browning, A. C., Garner, A. N., & Kelly, D. P.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Kelly, Daniel P.
- ORCID
- Kelly, Daniel P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 276
- Issue
- 48
- Pages
- 44495-44501
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1975717275
- Cited by
- 260
- References
- 47
- Citations by year
- 2025: 9 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 11 · 2019: 6 · 2018: 12 · 2017: 11 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 10 · 2012: 13
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6922 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003808-02, 5p50hl061006-05)
- National Heart, Lung, and Blood Institute (R01-HL-58493, K08 HL03808, P50-HL-61006, R01HL058493)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01 DK52574, P30-DK56341, P30DK056341)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- p38 MAPK, PPARα, protein phosphorylation, cardiomyocytes, fatty acid beta-oxidation, energy metabolism, PGC-1, transcriptional coactivation, ligand-dependent transactivation, stress-activated signaling, myocardial energy metabolism, mitochondrial biogenesis
- MeSH terms
- Adenoviridae, Amino Acid Sequence, Animals, Animals, Newborn, Binding Sites, Cell Line, Cells, Cultured, Chlorocebus aethiops, Enzyme Activation, Imidazoles, Molecular Sequence Data, Myocardium, Phosphates, Phosphorylation, Protein Binding, Pyridines, Serine, Time Factors, Transcription Factors, Transcription, Genetic, Transfection, Signal Transduction, Transcriptional Activation, Protein Structure, Tertiary, Receptors, Cytoplasmic and Nuclear, Dimerization, Oleic Acid, Two-Hybrid System Techniques, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, p38 Mitogen-Activated Protein Kinases, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.